Literature DB >> 21458551

Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.

Sherief Essa1, Jean Michel Rabanel, Patrice Hildgen.   

Abstract

In our previous study, PEG-g-PLA nanoparticles were developed and characterized. The aim of the present work is to investigate the effect of PEG grafting density (% PEG inserted onto poly(d, l)-lactide, PLA backbone) on both physicochemical and biological properties (mainly plasma protein binding and in vitro macrophage uptake) of PEG-g-PLA NPs. Rhodamine B (RHO) loaded NPs were prepared from a 1:1 (wt/wt) blend of PLA and PEG-g-PLA copolymer of varying PEG grafting density (1, 7, or 20% mol/mol of lactic acid monomer) by an o/w emulsion solvent evaporation method. These NPs were characterized with regard to their morphology, size, surface charge, loading efficiency, and rhodamine release. The extent of protein adsorption to the surface of different NPs was qualitatively investigated by dynamic light scattering technique. Additionally, the in vitro macrophage uptake following incubation of RAW 264.7 cells with rhodamine loaded PEG-g-PLA and PLA particles was investigated by confocal laser scanning microscopy (CLSM). The amount of NPs phagocytosed following incubation of RAW 264.7 cells with different concentrations of rhodamine loaded PLA or pegylated NPs for 24h at 37 °C was also determined by fluorescence spectroscopy. ALL lyophilized NPs showed larger diameter in the range of 300-400 nm compared to freshly prepared NPs suspension indicating particle aggregation upon lyophilization. % EE of rhodamine was found to be between 10% and 68% wt/wt depending on PEG grafting density. The higher the grafting density of PEG over PLA backbone, the more the entrapment efficiency. All pegylated NPs showed low zeta potential (close to zero) values. In vitro release analysis revealed that rhodamine leaked from all nanoparticles at a very slow rate at physiological pH, thus making it suitable for both imaging and uptake studies with RAW 264.7 cells. All PEG-g-PLA NPs of different PEG grafting density were well tolerated and exhibited no toxicity to RAW 264.7 cells as seen by cell proliferation assays. Cellular uptake of NPs was mainly dependent on polymer type as well as PEG grafting density. Grafted copolymer NPs resulted in lower degree of macrophage uptake compared to PLA NPs in macrophages cell lines. The higher the PEG grafting density, the lower the uptake of NPs by macrophage cells. Minimum NPs uptake for all the investigated concentrations was achieved when the PEG grafting density was 7% mol/mol of lactic acid. When increasing the PEG grafting density in the nanoparticles above 7%, no significant reduction in NPs phagocytosis was achieved. Thus, this study shows that the optimal PEG density required for designing stealth PEG-g-PLA NPs suitable for drug delivery applications might vary from 4 to 7%.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21458551     DOI: 10.1016/j.ijpharm.2011.02.039

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  17 in total

1.  The investigation on polyion complex micelles composed of diammonium glycyrrhizinate/poly(ethylene glycol)-glycidyltrimethylammonium chloride-grafted polyasparthydrazide.

Authors:  Hong Huo; Yikun Gao; Tianyi Wang; Haitao Jiang; Siling Wang; Tongying Jiang
Journal:  AAPS PharmSciTech       Date:  2012-10-02       Impact factor: 3.246

2.  Double or Simple Emulsion Process to Encapsulate Hydrophilic Oxytocin Peptide in PLA-PEG Nanoparticles.

Authors:  Betty Gourdon; Xavier Declèves; Jean-Manuel Péan; Caroline Chemin
Journal:  Pharm Res       Date:  2018-03-05       Impact factor: 4.200

3.  PEGylated silicon nanowire coated silica microparticles for drug delivery across intestinal epithelium.

Authors:  Vuk Uskoković; Phin Peng Lee; Laura A Walsh; Kathleen E Fischer; Tejal A Desai
Journal:  Biomaterials       Date:  2011-11-23       Impact factor: 12.479

4.  Tailoring the properties of mPEG-PLLA nanoparticles for better encapsulation and tuned release of the hydrophilic anticancer drug.

Authors:  Sachin S Surwase; Neha M Munot; Bhaskar B Idage; Susheela B Idage
Journal:  Drug Deliv Transl Res       Date:  2017-06       Impact factor: 4.617

Review 5.  Recent advances in stealth coating of nanoparticle drug delivery systems.

Authors:  Zohreh Amoozgar; Yoon Yeo
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2012-01-09

6.  The effect of nanoparticle polyethylene glycol surface density on ligand-directed tumor targeting studied in vivo by dual modality imaging.

Authors:  Sjoerd Hak; Emily Helgesen; Helga H Hektoen; Else Marie Huuse; Peter A Jarzyna; Willem J M Mulder; Olav Haraldseth; Catharina de Lange Davies
Journal:  ACS Nano       Date:  2012-06-06       Impact factor: 15.881

7.  Effect of Surface Modification on the In vitro Protein Adsorption and Cell Cytotoxicity of Vinorelbine Nanoparticles.

Authors:  Nandhakumar Sathyamoorthy; Dhanaraju Dasaratha Magharla; Sundar Devendaran Vankayalu
Journal:  J Pharm Bioallied Sci       Date:  2017 Apr-Jun

8.  A Simple and Sensitive Method to Quantify Biodegradable Nanoparticle Biodistribution using Europium Chelates.

Authors:  Lindsey Crawford; Jaclyn Higgins; David Putnam
Journal:  Sci Rep       Date:  2015-09-08       Impact factor: 4.379

9.  Enhanced detection with spectral imaging fluorescence microscopy reveals tissue- and cell-type-specific compartmentalization of surface-modified polystyrene nanoparticles.

Authors:  Kata Kenesei; Kumarasamy Murali; Árpád Czéh; Jordi Piella; Victor Puntes; Emília Madarász
Journal:  J Nanobiotechnology       Date:  2016-07-07       Impact factor: 10.435

10.  Manufacturing of a Secretoneurin Drug Delivery System with Self-Assembled Protamine Nanoparticles by Titration.

Authors:  Bernhard Scheicher; Cornelia Lorenzer; Katrin Gegenbauer; Julia Partlic; Fritz Andreae; Alexander H Kirsch; Alexander R Rosenkranz; Oliver Werzer; Andreas Zimmer
Journal:  PLoS One       Date:  2016-11-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.